Baird analyst Wesley Golladay lowered the firm’s price target on Healthpeak Properties (DOC) to $19 from $20 and keeps an Outperform rating on the shares. The firm updated its model to incorporate the Janus Living IPO.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOC:
- Citi cuts Healthpeak target, opens ‘upside 30-day catalyst watch’
- Healthpeak Properties Expands Credit Facilities to Enhance Liquidity
- Opening Day: Janus Living opens at $23.50 after upsized IPO
- Janus Living opens at $23.50, IPO priced at $20 per share
- Janus Living indicated to open at $23.50-$24, IPO priced at $20 per share